| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 03/12/2008 | CN100374416C P-(sulfonyl)-aryl and heteroaryls amines |
| 03/12/2008 | CN100374162C application of seasquirts-743 on preparing agent for the treatment of tumor |
| 03/12/2008 | CN100374157C Precursor N-acetylgalactosamine-4 sulfatase, methods of treatment using said enzyme and methods for producing and purifying said enzyme |
| 03/12/2008 | CN100374156C Health products for face care and body care |
| 03/12/2008 | CN100374135C Ginseng pills of sea dog |
| 03/12/2008 | CN100374125C Pharmaceutical compsn. contg. extract from barleria prionitis linn and its process of prepn |
| 03/12/2008 | CN100374115C Substituted diketopiperazines as oxytocin antagonists |
| 03/11/2008 | US7342106 Human antihuman MCP-1 antibody and antibody fragment thereof |
| 03/11/2008 | US7342043 Medicinal compositions improving brain function and method for improving brain function |
| 03/11/2008 | US7342034 Fused heterocyclic compounds and analogs thereof, modulators of nuclear hormone receptor function |
| 03/11/2008 | US7342032 Psychiatric and neurological disorders; cannabinoid (cb1) receptor; such as 4-(4-Chlorophenyl)-5-(2,4-dichlorophenyl)-N-(1-piperidinyl)thiazole-2-carboxamide |
| 03/11/2008 | US7342029 Substituted indoles |
| 03/11/2008 | US7342028 Medical use for tachykinin antagonists |
| 03/11/2008 | US7342022 Compounds in the treatment of dementia related diseases, Alzheimer's Disease and conditions associated with glycogen synthase kinase-3 |
| 03/11/2008 | US7342021 Phosphodiesterase 4 inhibitors |
| 03/11/2008 | US7342020 Effective against MMP 9 and 13; arthritis, atherosclerosis; synthesis |
| 03/11/2008 | US7342019 5, 6-diaryl-pyrazine-2-amide derivatives as CB1 antagonists |
| 03/11/2008 | US7342017 Vanilloid Receptor 1 and metabotropic glutamate receptor 1 inhibitors; inhibition of capsaicin-induced or PH-induced activation of vanilloid receptors; antidepressant; anxiolytic agent; analgesics; addictive disorders; antiemetic agent |
| 03/11/2008 | US7342016 Benzo(5,6)cyclohepta(1,2-b)pyridine derivatives; use in combination with antineoplastic agents such as cisplatin |
| 03/11/2008 | US7342015 Indole derivatives |
| 03/11/2008 | US7341996 Endothelial growth factor for use as diagnostic and preventative tool in treatment of cell proliferative disorders |
| 03/11/2008 | US7341995 Use of SARP-1 for the treatment and/or prevention of scleroderma |
| 03/11/2008 | US7341988 Method of treating influenza with geranyl-geranyl acetone |
| 03/11/2008 | US7341842 TRP8, a transient receptor potential channel expressed in taste receptor cells |
| 03/11/2008 | US7341730 Inhibitors of angiogenesis and tumor growth |
| 03/11/2008 | CA2444561C Biofunctional hydroxyapatite coatings and microspheres for in-situ drug encapsulation |
| 03/11/2008 | CA2421880C Resorcinol derivatives |
| 03/11/2008 | CA2404464C Pyrrolidine and piperidine derivatives and their use for the treatment of neurodegenerative disorders |
| 03/11/2008 | CA2402336C Concentrated solutions of carvedilol |
| 03/11/2008 | CA2335104C Arylalkanoylpyridazines |
| 03/11/2008 | CA2300358C Novel phytase |
| 03/11/2008 | CA2293382C Piperazine derivatives and their use as anti-inflammatory agents |
| 03/11/2008 | CA2290646C Triterpene saponin analogs having adjuvant and immunostimulatory activity |
| 03/11/2008 | CA2223535C 2,4-pentadienoic acid derivatives having retinoid-like biological activity |
| 03/11/2008 | CA2192764C Integrin receptor antagonists |
| 03/11/2008 | CA2126091C Novel biologically active polypeptides, preparation thereof and pharmaceutical composition containing said polypeptides |
| 03/06/2008 | WO2008028193A2 Colon-targeted oral formulations of cytidine analogs |
| 03/06/2008 | WO2008027932A2 Cytochrome p450 oxidase inhibitors and uses thereof |
| 03/06/2008 | WO2008027837A2 Small molecule potentiator of hormonal therapy for breast cancer |
| 03/06/2008 | WO2008026781A1 Reverse targeting lipid vesicle |
| 03/06/2008 | WO2008026769A1 Novel aminopyridine derivative having aurora a-selective inhibitory activity |
| 03/06/2008 | WO2008026768A1 Novel aminopyridine derivatives having aurora a selective inhibitory action |
| 03/06/2008 | WO2008026748A1 Antitumor agent for undifferentiated gastric cancer |
| 03/06/2008 | WO2008026704A1 Isoquinoline derivative |
| 03/06/2008 | WO2008026687A1 Pyrazolopyridine carboxamide derivative and phosphodiesterase (pde) inhibitor comprising the derivative |
| 03/06/2008 | WO2008026668A1 Medicinal composition containing insulin resistance improving agent |
| 03/06/2008 | WO2008026577A1 Method for producing phenoxypyridine derivative |
| 03/06/2008 | WO2008026564A1 Urea derivative |
| 03/06/2008 | WO2008026563A1 Hydrazine amide derivative |
| 03/06/2008 | WO2008026334A1 Agent for inhibiting intestinal permeation of allergen |
| 03/06/2008 | WO2008026320A1 ANTI-ANGIOGENIC AGENT, DNA SYNTHESIS INHIBITOR, p44/p42 MAPK PHOSPHORYLATION ACTIVITY INHIBITOR, AND MEDICAL KIT |
| 03/06/2008 | WO2008025787A2 Pharmaceutical compositions for the treatment of inflammatory or obstructive airway diseases |
| 03/06/2008 | WO2008011176A9 Myosin light chain kinase inhibitor compounds, compositions and related methods of use |
| 03/06/2008 | WO2008011174A3 Jak inhibitors for treatment of myeloproliferative disorders |
| 03/06/2008 | WO2008008513A3 Combination treatments |
| 03/06/2008 | WO2007100664A3 Modulators of muscarinic receptors |
| 03/06/2008 | US20080060088 Using transgenic animal model as screening tool in identifying agents for prevention and treatment of psychological disorders |
| 03/06/2008 | US20080059313 Contrary to this conventional wisdom, applicants have found that topical application of hair growth inhibitors to regions where the appearance of more hair is desired (e.g., scalp and/or beard area) can actually increase the appearance; up-regulates aquaporin-3 expression |
| 03/06/2008 | US20080058519 Quinazoline ditosylate salt compounds |
| 03/06/2008 | US20080058514 ceramide-like inhibitors; novel intermediates formed during the synthesis; Glycosphingolipids |
| 03/06/2008 | US20080058505 Modified parathyroid hormone/peptides for use in prevention and treatment of bone disorders |
| 03/06/2008 | US20080058433 Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof |
| 03/06/2008 | US20080058429 Diagnosis Of Primary Open Angle Glaucoma |
| 03/06/2008 | US20080058419 Treatment Of Poultry For Increasing The Feed Conversion Rate Or For Reducing The Incidence Of Ascites |
| 03/06/2008 | US20080058408 Low-dose doxepin for treatment of sleep disorders in elderly patients |
| 03/06/2008 | US20080058407 Methods of improving the pharmacokinetics of doxepin |
| 03/06/2008 | US20080058406 Lipoic acid derivatives |
| 03/06/2008 | US20080058405 Replicating melatonin signaling in a fetus, newborn or suckling infant |
| 03/06/2008 | US20080058404 Co-milling ramipril with lubricant selected from glyceryl behenate, polyethylene glycol, stearic acid, sodium stearyl fumarate, and combinations thereof; cardiovascular disorders; hypertension |
| 03/06/2008 | US20080058399 Candesartan or candesartan cilexetil; improved bioavailability |
| 03/06/2008 | US20080058395 Fused heterocyclic inhibitors of D-amino acid oxidase |
| 03/06/2008 | US20080058378 Compounds which have activity at M1 receptor and their uses in medicine. |
| 03/06/2008 | US20080058354 Treating erectile dysfunction and female sexual dysfunction; side effect reduction; 1-ethyl-3-(2-hydroxyethyl)-7-(3-bromo-4-methoxyphenyl)-8-(2-hydroxycyclopenylamino)-1,2,3,6-tetrahydro-7H-purine-2,6-dione for example |
| 03/06/2008 | US20080058351 Novel heterobicyclic compounds |
| 03/06/2008 | US20080058349 Cognitive impairment, Alzheimer's Disease, neurodegeneration and dementia; Beta site APP Cleaving Enzyme (BACE) inhibitors; beta-secretase inhibitors; 3,3-Difluoro-8-(2',6-difluoro-3'-methoxybiphenyl-3-yl)-8-pyridin-4-yl-2,3,4,8-tetrahydroimidazo[1,5-a]pyrimidin-6-amine acetate for example |
| 03/06/2008 | US20080058341 Azaindazole compounds and methods of use |
| 03/06/2008 | US20080058336 Secretase inhibitor |
| 03/06/2008 | US20080058335 Pain, inflammatory or immune disorders, neurological disorders, cancers of the immune system, respiratory disorders, cardiovascular disorders, neuroprotection; e.g. 5-chloro-N-[(2Z)-5-(1-hydroxy-1-methylethyl)-3-[((cis)-3-methoxycyclobutyl)methyl]-4-methyl-1,3-thiazol-2(3H)-ylidene]-2-methoxybenzamide |
| 03/06/2008 | US20080058334 Dermatological or oncological disorders; N-(4-fluorophenyl)-N'-[4-[1-(1H-imidazol-1-yl)-2-methylpropyl]phenyl]urea for example |
| 03/06/2008 | US20080058333 Carbamates such as (1-benzylcyclohexyl)methyl(1S)-5-[(4-morpholinylcarbonyl)amino]-1-(oxo([(1R)-1-phenylethyl]amino)acetyl)pentylcarbamate; osteoporosis |
| 03/06/2008 | US20080058329 Novel indane compounds |
| 03/06/2008 | US20080058327 4-piperazinyl-5H-6,7-dihydrocyclopenta(d)pyrimidines; Hyperproliferative diseases such as cancer |
| 03/06/2008 | US20080058326 Interfere with Tie2 signalling; Tie (tyrosine kinase with immunoglobulin and epidermal growth factor homology domain) receptor tyrosine kinase; antitumor, antimetastasis agents; for example, 1-[4-(6-tert-Butyl-1H-pyrazolo[3,4-b]pyridin-4-yl)-phenyl]-3-(3-ethyl-phenyl)-urea |
| 03/06/2008 | US20080058322 Small molecule inhibitors targeted at Bcl-2 |
| 03/06/2008 | US20080058321 Benzothiazin-3-one compound and intermediate therefor |
| 03/06/2008 | US20080058317 Administering high dosage |
| 03/06/2008 | US20080058316 Cancer treatment with gama-secretase inhibitors |
| 03/06/2008 | US20080058314 Novel dicarboxylic acid derivatives with pharmaceutical properties |
| 03/06/2008 | US20080058311 Antagonizing N-type calcium channels; use as analgesic, neurodegenerative diseases, brain injury, bronchial asthma, unstable angina and irritable colitis, drug withdrawal symptoms; t-butyl 2-[4-(5H-dibenzo[a,d][7]annulen-5-ylidene)-1-piperidinyl]-2-oxoethylcarbamate for example |
| 03/06/2008 | US20080058306 Combinations of peroxisome proliferator-activated receptor (PPAR) activator(s) and sterol absorption inhibitors(s) and treatments for vascular indications |
| 03/06/2008 | US20080058304 Inhibitors of UPD-3-O (R-3-hydroxymyristoyl)-N-acetylglucosamine deacetylase, an enzyme present in gram negative bacteria; azetidine, pyrrolidine, or 3-pyrroline 2-carboxylic acid hydroxyamides; 1-(3,4-dimethoxy-5-propylbenzoyl)pyrrolidine-2R-carboxylic acid hydroxyamide for example |
| 03/06/2008 | US20080058301 Therapy for prostate cancer; administering androgen receptor |
| 03/06/2008 | US20080058295 Nasal pharmaceutical formulations and methods of using the same |
| 03/06/2008 | US20080058294 Glucocorticoid encapsulated within liposome; multiple sclerosis, anticancer agents |
| 03/06/2008 | US20080058290 Substituted Phenoxy-and Phenylthio-Derivatives for Treating Proliferative Disorders |
| 03/06/2008 | US20080058287 Mesotherapy Cream |
| 03/06/2008 | US20080058279 Such as 3-[4-(2-Octadec-9-enyloxycarbonyl-ethylamino)-butylamino]-propionic acid octadec-9-enyl ester dihydrochloride salt; use with vectors for in vivo transfection |
| 03/06/2008 | US20080058277 Methods and compositions for modulating telomerase reverse transcriptase (TERT) expression |
| 03/06/2008 | US20080058275 Rna Interferases And Methods Of Use Thereof |
| 03/06/2008 | US20080058274 Mixture of active drugs in stable lipids; forming liposomes; doxorubicins encapsulated with ceramide |